Gastric Bypass Clinical Trial
— MGB vs RYGBOfficial title:
Mini Gastric Bypass vs Roux enY Gastric Bypass
Verified date | July 2019 |
Source | Doncaster And Bassetlaw Hospitals NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary aim of this research project is to assess the safety and efficacy of the MGB operation in the UK
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | July 24, 2019 |
Est. primary completion date | July 24, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - They have a BMI of 40 kg/m2 or more, or between 35 kg/m2 and 40 kg/m2 and other significant disease (for example, type 2 diabetes or high blood pressure) that could be improved if they lost weight. - All appropriate non-surgical measures have been tried but the person has not achieved or maintained adequate, clinically beneficial weight loss. - The person has been receiving or will receive intensive management in a tier 3 service. - The person is generally fit for anaesthesia and surgery. - The person commits to the need for long-term follow-up Exclusion Criteria: - Not meeting the eligibility criteria - Under 18s |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Doncaster & Bassetlaw Teaching Hospitals NHS Foundation Trust | Doncaster | South Yorkshire |
Lead Sponsor | Collaborator |
---|---|
Doncaster And Bassetlaw Hospitals NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Excess weight loss | Amount of weight lost | 2 years post surgery | |
Secondary | Type 2 diabetes remission | Type 2 diabetes remission | 6 months, 2 years, 5 years and 10 years | |
Secondary | Morbidity | Morbidity | 6 months, 2 years, 5 years and 10 years | |
Secondary | Mortality | Mortality | 6 months, 2 years, 5 years and 10 years | |
Secondary | Operative time | Operative time | 6 months, 2 years, 5 years and 10 years | |
Secondary | Length of stay | Length of stay | 6 months, 2 years, 5 years and 10 years | |
Secondary | Readmission rate | Readmission rate | 6 months, 2 years, 5 years and 10 years | |
Secondary | Lipid profile | Lipid profile | 6 months, 2 years, 5 years and 10 years | |
Secondary | Malnutrition | Malnutrition | 6 months, 2 years, 5 years and 10 years | |
Secondary | Liver failure | Liver failure | 6 months, 2 years, 5 years and 10 years | |
Secondary | Gastro-oesophageal reflux | Gastro-oesophageal reflux | 6 months, 2 years, 5 years and 10 years | |
Secondary | Upper GI cancer | Upper GI cancer | 6 months, 2 years, 5 years and 10 years | |
Secondary | Diarrhoea | Diarrhoea | 6 months, 2 years, 5 years and 10 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00535600 -
Effects of Bariatric Surgery on Insulin
|
||
Not yet recruiting |
NCT01652105 -
Randomized Trial of Preoperative Diets Before Bariatric Surgery
|
N/A | |
Completed |
NCT01013051 -
Effect of Gastric Bypass on the Absorption of Metformin
|
N/A | |
Completed |
NCT04082923 -
Effect of Meal Texture on Glucose-metabolism and Gut Hormone Response After Bariatric Surgery
|
N/A | |
Completed |
NCT01867255 -
Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels
|
Phase 1 | |
Active, not recruiting |
NCT00996294 -
Surgical Treatment of Type 2 Diabetes Mellitus in <35 Body Mass Index (BMI)
|
N/A | |
Completed |
NCT00549237 -
Perioperative Nutrition in Gastric Bypass Surgery
|
N/A | |
Completed |
NCT00488423 -
Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery
|
Phase 1 | |
Completed |
NCT02819037 -
Small Intestinal Bacterial Overgrowth Obese
|
N/A | |
Completed |
NCT01130922 -
Pharmacokinetic Evaluation of Moxifloxacin Administered Intravenously and Orally in Healthy Volunteers Who Have Had a Gastric Bypass
|
Phase 4 | |
Terminated |
NCT02483598 -
Mechanistic Investigation Of Intestinal Cytochrome p450 3A4 Following Roux-en-Y Surgery And Its Effect on Plasma Concentrations of Buspirone
|
Phase 4 | |
Recruiting |
NCT04832282 -
Napoleon Measurement of Gastrojejunal Anastomosis
|
Early Phase 1 | |
Completed |
NCT04332289 -
Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment.
|
||
Completed |
NCT06298162 -
Assessment of Pouch Emptying With MRI After Roux-en-Y Gastric Bypass
|
||
Recruiting |
NCT02823665 -
The Effects of Bariatric Surgeries on Glucose Metabolism
|
Early Phase 1 | |
Recruiting |
NCT02118844 -
Laparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical Conditions
|
Phase 4 | |
Completed |
NCT01330914 -
Effects of Gastric Bypass Surgery and Calcium Metabolism and the Skeleton
|
||
Completed |
NCT01138475 -
Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery
|
Phase 3 | |
Completed |
NCT01015157 -
Prospective Trial Using Gastric Stapling Line Reinforcement With Seamguard in Roux-en-Y Gastric Bypass
|
N/A | |
Completed |
NCT00841009 -
Effect of Gastric Bypass-induced Weight Loss on Myocardial Structure, Function and Metabolism
|
N/A |